ATLANTA, Feb. 14, 2013 /PRNewswire/ --
Full Year Highlights:-
-
Total revenues grew 10% year-over-year to a record $131.7 million-
Product revenues grew 14% year-over-year to $67.5 million-
Tissue processing revenues grew 6% year-over-year to $63.6 million-
Generated $19.0 million in cash flow from operations-
-
Fourth Quarter Highlights:-
-
Total revenues grew 8% year-over-year to a record $32.8 million-
Product revenues grew 13% year-over-year to $17.5 million-
Tissue processing revenues grew 3% year-over-year to $15.2 million-
Generated $8.0 million in cash flow from operations
CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today its results for the fourth quarter and full year of 2012. Revenues for the fourth quarter of 2012 increased 8 percent to a record $32.8 million compared to $30.4 million for the fourth quarter of 2011. Revenues for the full year of 2012 increased 10 percent to a record $131.7 million compared to $119.6 million for the full year of 2011. PR Newswire (http://s.tt/1zMrQ)
